This project is no longer listed in the FindAPhD
database and may not be available.
This studentship is fully funded by York Against Cancer and covers: (i) a tax-free stipend at the standard Research Council rate (£14,296 for 2016-2017 but typically increases annually in line with inflation) and (ii) tuition fees at the UK/EU rate. The studentship is available to UK and EU students.
1. Varley CL, Bacon EJ, Holder JC, Southgate J. FOXA1 and IRF-1 intermediary transcriptional regulators of PPARgamma-induced urothelial cytodifferentiation. Cell Death Differ. 2009;16:103-14. PMID: 18688264.
2. Varley C, Hill G, Pellegrin S, Shaw NJ, Selby PJ, Trejdosiewicz LK, Southgate J. Autocrine regulation of human urothelial cell proliferation and migration during regenerative responses in vitro. Exp Cell Res. 2005;306:216-29. PMID: 15878346.
3. Rebouissou S, Bernard-Pierrot I, de Reynies A, Lepage ML, Krucker C, Chapeaublanc E, Herault A, Kamoun A, Caillault A, Letouze E, Elarouci N, Neuzillet Y, Denoux Y, Molinie V, Vordos D, Laplanche A, Maille P, Soyeux P, Ofualuka K, Reyal F, Biton A, Sibony M, Paoletti X, Southgate J, Benhamou S, Lebret T, Allory Y, Radvanyi F. EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype. Sci Transl Med. 2014;6:244ra91. PMID: 25009231.
4. Fleming JM, Shabir S, Varley CL, Kirkwood LA, White A, Holder J, Trejdosiewicz LK, Southgate J. Differentiation-associated reprogramming of the transforming growth factor beta receptor pathway establishes the circuitry for epithelial autocrine/paracrine repair. PLoS One. 2012;7:e51404. PMID: 23284691.
FTE Category A staff submitted: 44.37
Research output data provided by the Research Excellence Framework (REF)Click here to see the results for all UK universities